These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31070479)

  • 1. Liquid Biopsy of Extracellular Microvesicles Predicts Future Major Ischemic Events in Genetically Characterized Familial Hypercholesterolemia Patients.
    Suades R; Padró T; Crespo J; Sionis A; Alonso R; Mata P; Badimon L
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1172-1181. PubMed ID: 31070479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High miR-133a levels in the circulation anticipates presentation of clinical events in familial hypercholesterolaemia patients.
    Escate R; Padró T; Suades R; Camino S; Muñiz O; Diaz-Diaz JL; Sionis A; Mata P; Badimon L
    Cardiovasc Res; 2021 Jan; 117(1):109-122. PubMed ID: 32061123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid Biopsy of Extracellular Microvesicles Maps Coronary Calcification and Atherosclerotic Plaque in Asymptomatic Patients With Familial Hypercholesterolemia.
    Chiva-Blanch G; Padró T; Alonso R; Crespo J; Perez de Isla L; Mata P; Badimon L
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):945-955. PubMed ID: 30866660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD142+/CD61+, CD146+ and CD45+ microparticles predict cardiovascular events in high risk patients following a Mediterranean diet supplemented with nuts.
    Chiva-Blanch G; Crespo J; Suades R; Arderiu G; Padro T; Vilahur G; Cubedo J; Corella D; Salas-Salvadó J; Arós F; Martínez-González MA; Ros E; Fitó M; Estruch R; Badimon L
    Thromb Haemost; 2016 Jul; 116(1):103-14. PubMed ID: 27052787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis.
    Suades R; Padró T; Alonso R; Mata P; Badimon L
    Thromb Haemost; 2015 Nov; 114(6):1310-21. PubMed ID: 26178021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
    Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating CD45+/CD3+ lymphocyte-derived microparticles map lipid-rich atherosclerotic plaques in familial hypercholesterolaemia patients.
    Suades R; Padró T; Alonso R; López-Miranda J; Mata P; Badimon L
    Thromb Haemost; 2014 Jan; 111(1):111-21. PubMed ID: 24085382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry.
    Bourbon M; Alves AC; Alonso R; Mata N; Aguiar P; Padró T; Mata P
    Atherosclerosis; 2017 Jul; 262():8-13. PubMed ID: 28475941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia.
    Cubedo J; Padró T; Alonso R; Mata P; Badimon L
    J Lipid Res; 2016 Jun; 57(6):1059-73. PubMed ID: 27112635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of platelet-derived microvesicles and their phenotypes with carotid atherosclerosis and recurrent vascular events in patients after ischemic stroke.
    Rosińska J; Ambrosius W; Maciejewska J; Narożny R; Kozubski W; Łukasik M
    Thromb Res; 2019 Apr; 176():18-26. PubMed ID: 30763823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
    Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of premature familial arterial thrombosis in patients with juvenile ischaemic stroke. The Italian Project on Stroke in Young Adults (IPSYS).
    Pezzini A; Grassi M; Lodigiani C; Patella R; Gandolfo C; Zini A; DeLodovici ML; Paciaroni M; Del Sette M; Toriello A; Musolino R; Calabrò RS; Bovi P; Adami A; Silvestrelli G; Sessa M; Cavallini A; Marcheselli S; Bonifati DM; Checcarelli N; Tancredi L; Chiti A; Del Zotto E; Spalloni A; Costa P; Giacalone G; Ferrazzi P; Poli L; Morotti A; Rasura M; Simone AM; Gamba M; Cerrato P; Micieli G; Melis M; Massucco D; De Giuli V; Pepe D; Iacoviello L; Padovani A;
    Thromb Haemost; 2015 Mar; 113(3):641-8. PubMed ID: 25413729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin V
    Bratseth V; Margeirsdottir HD; Chiva-Blanch G; Heier M; Solheim S; Arnesen H; Dahl-Jørgensen K; Seljeflot I
    J Diabetes Res; 2020; 2020():7216863. PubMed ID: 32309448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
    Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P
    J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR; Martin FJ; Spirk D
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
    Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
    Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.
    Kjærgaard KA; Christiansen MK; Schmidt M; Olsen MS; Jensen HK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28652386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil.
    Souto AC; Miname MH; Fukushima J; Jannes CE; Krieger JE; Hagger M; Pereira AC; Santos RD
    Atherosclerosis; 2018 Oct; 277():464-469. PubMed ID: 30270086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile.
    Scicali R; Di Pino A; Platania R; Purrazzo G; Ferrara V; Giannone A; Urbano F; Filippello A; Rapisarda V; Farruggia E; Piro S; Rabuazzo AM; Purrello F
    Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):35-43. PubMed ID: 28958694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.